Literature DB >> 28804548

Overexpression of PTEN suppresses non-small-cell lung carcinoma metastasis through inhibition of integrin αVβ6 signaling.

Yan Xia Yu1, Yi Wang1, Hong Liu1.   

Abstract

Studies have demonstrated that the abnormal expression of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is associated with multiple malignancies, but its functional role in non-small-cell lung carcinoma (NSCLC) metastasis remains to be elucidated. In the present study, we investigated the role of PTEN in regulating proliferation, migration, and invasion of NSCLC cells by establishing NSCLC cell strains with constitutively silenced or elevated PTEN expression. We demonstrated that ectopic expression of PTEN inhibits migration and invasion of NSCLC cells in vitro through wound healing and Transwell invasion assays. Furthermore, PTEN overexpression in NSCLC cells greatly inhibits cell viability and colony formation, which was confirmed by MTT and colony formation assays. Conversely, further analysis indicated that suppression of PTEN expression via shRNA promotes metastasis and growth of NSCLC cells. Finally, our findings demonstrate that PTEN promotes invasion and migration of NSCLC cells through the integrin αVβ6 signaling pathway. Overall, this study provides novel insights into the role of PTEN as a crucial regulator of NSCLC cell metastasis, and suggests that targeted treatment of PTEN-expressing tumors serves as a new therapeutic target for NSCLC.

Entities:  

Keywords:  NSCLC; PTEN; integrin αVβ6; metastasis

Year:  2017        PMID: 28804548      PMCID: PMC5553880     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  23 in total

1.  Inhibition of RAB1A suppresses epithelial-mesenchymal transition and proliferation of triple-negative breast cancer cells.

Authors:  Hui Xu; Mingping Qian; Bingkun Zhao; Chenyang Wu; Niraj Maskey; Hongming Song; Dengfeng Li; Jialu Song; Kaiyao Hua; Lin Fang
Journal:  Oncol Rep       Date:  2017-01-25       Impact factor: 3.906

2.  Suppression of PTEN/AKT signaling decreases the expression of TUBB3 and TOP2A with subsequent inhibition of cell growth and induction of apoptosis in human breast cancer MCF-7 cells via ATP and caspase-3 signaling pathways.

Authors:  Zhenhua Yang; Ying Liu; Changzheng Shi; Yuqin Zhang; Rongzhao Lv; Rong Zhang; Qian Wang; Yiming Wang
Journal:  Oncol Rep       Date:  2017-01-09       Impact factor: 3.906

3.  Surgical Treatment of Extrapulmonary Oligometastatic Non-small Cell Lung Cancer.

Authors:  Till Plönes; Thomas Osei-Agyemang; Alexander Krohn; Bernward Passlick
Journal:  Indian J Surg       Date:  2012-12-14       Impact factor: 0.656

4.  Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients.

Authors:  Shuta Tomida; Katsumi Koshikawa; Yasushi Yatabe; Tomoko Harano; Nobuhiko Ogura; Tetsuya Mitsudomi; Masato Some; Kiyoshi Yanagisawa; Toshitada Takahashi; Hirotaka Osada; Takashi Takahashi
Journal:  Oncogene       Date:  2004-07-08       Impact factor: 9.867

5.  MicroRNA-494 inhibits cell proliferation and invasion of chondrosarcoma cells in vivo and in vitro by directly targeting SOX9.

Authors:  Jingyuan Li; Lijuan Wang; Zongzhi Liu; Chao Zu; Fanfan Xing; Pei Yang; Yongkang Yang; Xiaoqian Dang; Kunzheng Wang
Journal:  Oncotarget       Date:  2015-09-22

6.  Natural History of Non-Small-Cell Lung Cancer with Bone Metastases.

Authors:  Daniele Santini; Santini Daniele; Sandro Barni; Barni Sandro; Salvatore Intagliata; Intagliata Salvatore; Alfredo Falcone; Falcone Alfredo; Francesco Ferraù; Ferraù Francesco; Domenico Galetta; Galetta Domenico; Luca Moscetti; Moscetti Luca; Nicla La Verde; La Verde Nicla; Toni Ibrahim; Ibrahim Toni; Fausto Petrelli; Petrelli Fausto; Enrico Vasile; Vasile Enrico; Laura Ginocchi; Ginocchi Laura; Davide Ottaviani; Ottaviani Davide; Flavia Longo; Longo Flavia; Cinzia Ortega; Ortega Cinzia; Antonio Russo; Russo Antonio; Giuseppe Badalamenti; Badalamenti Giuseppe; Elena Collovà; Collovà Elena; Gaetano Lanzetta; Lanzetta Gaetano; Giovanni Mansueto; Mansueto Giovanni; Vincenzo Adamo; Adamo Vincenzo; Filippo De Marinis; De Marinis Filippo; Maria Antonietta Satolli; Flavia Cantile; Cantile Flavia; Andrea Mancuso; Mancuso Andrea; Francesca Maria Tanca; Raffaele Addeo; Addeo Raffaele; Marco Russano; Russano Marco; Michelle Sterpi; M Sterpi; Francesco Pantano; Pantano Francesco; Bruno Vincenzi; Vincenzi Bruno; Giuseppe Tonini; Tonini Giuseppe
Journal:  Sci Rep       Date:  2015-12-22       Impact factor: 4.379

7.  MicroRNA-101 suppresses progression of lung cancer through the PTEN/AKT signaling pathway by targeting DNA methyltransferase 3A.

Authors:  Lumin Wang; Jiayi Yao; Hongfei Sun; Kang He; Dongdong Tong; Tusheng Song; Chen Huang
Journal:  Oncol Lett       Date:  2016-11-23       Impact factor: 2.967

8.  Specific KRAS amino acid substitutions and EGFR mutations predict site-specific recurrence and metastasis following non-small-cell lung cancer surgery.

Authors:  Stéphane Renaud; Joseph Seitlinger; Pierre-Emmanuel Falcoz; Mickaël Schaeffer; Anne-Claire Voegeli; Michèle Legrain; Michèle Beau-Faller; Gilbert Massard
Journal:  Br J Cancer       Date:  2016-06-23       Impact factor: 7.640

9.  EGFR protein expression using a specific intracellular domain antibody and PTEN and clinical outcomes in squamous cell lung cancer patients with EGFR-tyrosine kinase inhibitor therapy.

Authors:  Hyun Chang; Jisu Oh; Xianglan Zhang; Yu Jung Kim; Jae Ho Lee; Choon-Taek Lee; Jin-Haeng Chung; Jong-Seok Lee
Journal:  Onco Targets Ther       Date:  2016-08-19       Impact factor: 4.147

10.  Integrin α6/Akt/Erk signaling is essential for human breast cancer resistance to radiotherapy.

Authors:  Ting Hu; Rui Zhou; Yanxia Zhao; Gang Wu
Journal:  Sci Rep       Date:  2016-09-14       Impact factor: 4.379

View more
  5 in total

1.  MicroRNA-214 inhibits the proliferation and invasion of lung carcinoma cells by targeting JAK1.

Authors:  Xiaofeng Chen; Jiangyuan Du; Rui Jiang; Ling Li
Journal:  Am J Transl Res       Date:  2018-04-15       Impact factor: 4.060

2.  Overcoming of Radioresistance in Non-small Cell Lung Cancer by microRNA-320a Through HIF1α-Suppression Mediated Methylation of PTEN.

Authors:  Li-Ming Xu; Hao Yu; Ya-Jing Yuan; Jiao Zhang; Yue Ma; Xu-Chen Cao; Jun Wang; Lu-Jun Zhao; Ping Wang
Journal:  Front Cell Dev Biol       Date:  2020-11-10

Review 3.  PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?

Authors:  Nicola Fusco; Elham Sajjadi; Konstantinos Venetis; Gabriella Gaudioso; Gianluca Lopez; Chiara Corti; Elena Guerini Rocco; Carmen Criscitiello; Umberto Malapelle; Marco Invernizzi
Journal:  Genes (Basel)       Date:  2020-06-28       Impact factor: 4.096

4.  Hypoxic Microenvironment-Induced Reduction in PTEN-L Secretion Promotes Non-Small Cell Lung Cancer Metastasis through PI3K/AKT Pathway.

Authors:  Xuyang Song; Jinxi He; Bingqing Shi; Yuning Han
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-02       Impact factor: 2.629

5.  Clinical Significance of C-X-C Motif Chemokine Receptor 4 and Integrin αvβ6 Expression in Breast Cancer.

Authors:  Hongshan Huang; Mengci Yuan; Shuang-Ling Wu; Jinling Ba; Xinmiao Yu; Xiaoyun Mao; Feng Jin
Journal:  J Breast Cancer       Date:  2020-04-06       Impact factor: 3.588

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.